Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy

The application of nanoparticle drug formulations, such as nanoliposomal doxorubicin (Doxil), is increasingly integrated in clinical cancer care. Despite nanomedicine's remarkable potential and growth over the last three decades, its clinical benefits for cancer patients vary. Here we report a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Medina, Carlos, Abdel-Atti, Dalya, Tang, Jun, Zhao, Yiming, Fayad, Zahi A., Lewis, Jason S., Mulder, Willem J. M., Reiner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915130/
https://www.ncbi.nlm.nih.gov/pubmed/27319780
http://dx.doi.org/10.1038/ncomms11838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915130/
https://www.ncbi.nlm.nih.gov/pubmed/27319780
http://dx.doi.org/10.1038/ncomms11838

Ejemplares similares